Skyline Medical Announces 24 New STREAMWAY® System Installations for Large National Ambulatory Surgery Network
MINNEAPOLIS, May 28, 2014 /PRNewswire/ -- Skyline Medical Inc. (OTCQB: SKLN) is continuing to install a total of 24 new direct-to-drain STREAMWAY Fluid Waste Management Systems across the U.S. for an existing Skyline client. The client is one of the largest ambulatory networks in the United States and the shipments are being installed across surgical facilities in Texas, Minnesota, Arizona, Utah and Wisconsin.
"Generating repeat orders from our existing client base is a testament to the quality of the STREAMWAY system. We are continuing to receive positive feedback from our customers as more medical staff across the U.S. experience the safety benefits associated with the STREAMWAY system," stated Skyline Medical CEO, Josh Kornberg.
Kornberg continued, "We have a unique and reliable product which enables medical facilities to handle surgical waste in a safe and efficient way, while also making long term cost savings.
We are pleased that we are generating revenue from existing customers alongside new clients, and remain focused on developing and nurturing strong customer relationships as we drive our commercialization efforts through 2014."
These 24 installations are among 42 purchase orders previously announced with one of the largest networks of ambulatory surgical centers (ASCs) in the United States.
About Skyline Medical Inc.
Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods — which require hand carrying and emptying filled-fluid canisters — present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with Occupational State and Health Association (OSHA) and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments — leading to greater profitability, and 4) provide greater environmental
stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit: www.skylinemedical.com.
Forward-looking Statements
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, inability to raise sufficient additional capital to operate our business; approximately $2.7 million in debts, liabilities and cash obligations that become due over the next twelve months; unexpected costs and operating deficits, and lower than expected sales and revenues, if any; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to
establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a
solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the Company's most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.
Skyline Investor Relations Contacts: Phil Carlson / Elizabeth Barker KCSA Strategic Communications 212-896-1233 / 212-896-1203 skyline@kcsa.com
